Italian nonprofit Fondazione Telethon and US nonprofit Orphan Therapeutics Accelerator are collaborating to bring curative ...
The firm has closed an oversubscribed Series B, fueling two bold TCR-bispecific programs targeting cancer and autoimmune ...
Reverse mergers promise fast access to public markets – but DeeDee DeMan warns founders that leadership and governance readiness often lag behind.
Alethio Therapeutics has closed an oversubscribed $90 million Series A, providing the capital to advance to clinical stage.
AbbVie is paying up front and betting on a Japanese biotech's gut-restricted molecule to tackle inflammatory bowel disease ...
Boehringer Ingelheim and Microsoft are partnering to build AI-driven digital patient twins that simulate disease progression ...
The biotech has raised $25 million to scale its human cell models, targeting industry-standard status as drug discovery ...
Anthropic wants to use AI to address common bottlenecks in clinical trials and says collaborations with B-MS and Enveda – as ...
GSK leader shares tips on how to always keep mature brand speaker programs relevant, credible and compliant over time.
Some have called this announcement a "yellow light" or "backdoor" approval of these gray-market peptides. However, the HHS ...
Rhythm Pharmaceuticals has amended its exclusive license agreement with LG Chem for bivamelagon, an oral small-molecule ...
START and IFO launch a new early-phase cancer trial site in Rome, giving patients access to novel investigational treatments ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results